Literature DB >> 25081753

Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas.

Hitomi Sakamoto1, Yuko Kuboki2, Takashi Hatori3, Masakazu Yamamoto3, Masanori Sugiyama4, Noriyuki Shibata5, Kyoko Shimizu6, Keiko Shiratori6, Toru Furukawa2.   

Abstract

Mutations in RNF43, which encodes the ubiquitin E3 ligase ring finger protein 43, were recently found in intraductal papillary mucinous neoplasms of the pancreas. We evaluated somatic mutations of RNF43 and the expression of ring finger protein 43 as well as their associations with the molecular and clinicopathological features in 176 surgically resected intraductal papillary mucinous neoplasms. Frozen tissues were available for 57 cases and were used for next-generation sequencing analysis of the entire coding exons of RNF43. Formalin-fixed and paraffin-embedded tissues from all 176 cases were used for the immunohistochemical analysis of the expression of ring finger protein 43. Mutations detected with the next-generation sequencing analysis were validated by using Sanger sequencing. Statistical analysis was used to evaluate the associations between RNF43 aberrations and molecular and clinicopathological features including GNAS mutations, KRAS mutations, loss of SMA and MAD4 homologue expression, tumor protein 53 overexpression, tumor grade, histological type, mural nodule detection, macroscopic type, stage, recurrence, and survival. Somatic RNF43 mutations were found in 8 (14%) of the 57 examined cases, and included 5 frameshift mutations (p.F69fs, p.S264fs, p.L311fs, p.R363fs, and p.V490fs), 1 non-sense mutation (p.Q153X), and 2 missense mutations (p.I164N and p.P310A). The expression of ring finger protein 43 was downregulated in 52 (29.5%) of the 176 examined cases. RNF43 mutations were significantly associated with the downregulated expression of ring finger protein 43 (P=0.011), GNAS mutation (P=0.020), and mural nodule detection (P=0.038). The expression of ring finger protein 43 was not associated with any clinicopathological features except RNF43 mutation. These results indicate that RNF43 mutation might cause downregulation of the expression of ring finger protein 43 and play a crucial role and associate synergistically with GNAS mutation during development of intraductal papillary mucinous neoplasm of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081753     DOI: 10.1038/modpathol.2014.98

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

2.  Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Toru Furukawa; Rumi Fujisaki; Yoshitaro Yoshida; Naomi Kanai; Makoto Sunamura; Tadayoshi Abe; Kazunori Takeda; Seiki Matsuno; Akira Horii
Journal:  Mod Pathol       Date:  2005-08       Impact factor: 7.842

3.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.

Authors:  Jian Wu; Yuchen Jiao; Marco Dal Molin; Anirban Maitra; Roeland F de Wilde; Laura D Wood; James R Eshleman; Michael G Goggins; Christopher L Wolfgang; Marcia I Canto; Richard D Schulick; Barish H Edil; Michael A Choti; Volkan Adsay; David S Klimstra; G Johan A Offerhaus; Alison P Klein; Levy Kopelovich; Hannah Carter; Rachel Karchin; Peter J Allen; C Max Schmidt; Yoshiki Naito; Luis A Diaz; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

4.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.

Authors:  Bon-Kyoung Koo; Maureen Spit; Ingrid Jordens; Teck Y Low; Daniel E Stange; Marc van de Wetering; Johan H van Es; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Hans Clevers
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

5.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping.

Authors:  T Furukawa; T Takahashi; M Kobari; S Matsuno
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

8.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.

Authors:  Simon A Forbes; Nidhi Bindal; Sally Bamford; Charlotte Cole; Chai Yin Kok; David Beare; Mingming Jia; Rebecca Shepherd; Kenric Leung; Andrew Menzies; Jon W Teague; Peter J Campbell; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

9.  CDD: conserved domains and protein three-dimensional structure.

Authors:  Aron Marchler-Bauer; Chanjuan Zheng; Farideh Chitsaz; Myra K Derbyshire; Lewis Y Geer; Renata C Geer; Noreen R Gonzales; Marc Gwadz; David I Hurwitz; Christopher J Lanczycki; Fu Lu; Shennan Lu; Gabriele H Marchler; James S Song; Narmada Thanki; Roxanne A Yamashita; Dachuan Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

10.  A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.

Authors:  Hirotake Komatsu; Etsuko Tanji; Naoaki Sakata; Takeshi Aoki; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Shinichi Egawa; Michiaki Unno; Toru Furukawa
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  19 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

2.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.

Authors:  Shan Li; Marla Lavrijsen; Aron Bakker; Marcin Magierowski; Katarzyna Magierowska; Pengyu Liu; Wenhui Wang; Maikel P Peppelenbosch; Ron Smits
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

Review 3.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

4.  ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Tumour Biol       Date:  2016-07-22

Review 5.  Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.

Authors:  Y Lin; Z Wu; W Guo; J Li
Journal:  Tumour Biol       Date:  2015-09-12

6.  The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma.

Authors:  Dadong Wang; Jingwang Tan; Yong Xu; Mingming Han; Yuliang Tu; Ziman Zhu; Chunqing Dou; Jin Xin; Xianglong Tan; Jian-Ping Zeng; Gang Zhao; Zhiwei Liu
Journal:  Tumour Biol       Date:  2015-08-05

7.  Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.

Authors:  Giada Munari; Gianluca Businello; Paola Mattiolo; Angelo Paolo Dei Tos; Matteo Fassan; Gianmaria Pennelli; Marta Sbaraglia; Chiara Borga; Salvatore Pucciarelli; Gaya Spolverato; Claudia Mescoli; Francesca Galuppini; Antonio Sommariva; Elena Bellan; Sara Lonardi; Fotios Loupakis; Claudio Luchini
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-12       Impact factor: 4.553

Review 8.  KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Authors:  Ju-Han Lee; Younghye Kim; Jung-Woo Choi; Young-Sik Kim
Journal:  Springerplus       Date:  2016-07-26

9.  A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors.

Authors:  Yasuki Hijikata; Toshihiko Okazaki; Yoshihiro Tanaka; Mutsunori Murahashi; Yuichi Yamada; Kazunari Yamada; Atsushi Takahashi; Hiroyuki Inoue; Junji Kishimoto; Yoichi Nakanishi; Yoshinao Oda; Yusuke Nakamura; Kenzaburo Tani
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

10.  Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.

Authors:  Krushna C Patra; Nabeel Bardeesy; Yusuke Mizukami
Journal:  Clin Transl Gastroenterol       Date:  2017-04-06       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.